NOVEL MCH RECEPTOR ANTAGONISTS

The present invention relates to a melanin concentrating hormone antagonist compound of formula I: or a pharmaceutically acceptable salt thereof, useful for the treamtment useful fog treating Type H diabetes and/or obesity. La présente invention concerne un composé antagoniste de l'hormone conc...

Full description

Saved in:
Bibliographic Details
Main Authors MORIN, JOHN, MICHAEL, JUNIOR, KINNICK, MICHAEL, DEAN, NAVARRO, MARTINEZ, ANTONIO, GILLIG, JAMES, RONALD
Format Patent
LanguageEnglish
French
Published 28.09.2006
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a melanin concentrating hormone antagonist compound of formula I: or a pharmaceutically acceptable salt thereof, useful for the treamtment useful fog treating Type H diabetes and/or obesity. La présente invention concerne un composé antagoniste de l'hormone concentrant la mélanine (MCH) représenté par la formule (I), ou un sel pharmaceutiquement acceptable de ce composé, servant au traitement du diabète de type II et/ou de l'obésité.
Bibliography:Application Number: WO2004US32314